(object) array( 'id' => '1460561', 'url' => 'SR/thrombolytic_therapy', 'image' => '', 'title' => 'trombolitička terapija', 'tags' => array ( 0 => 'trombolitička terapija', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'trombolitička terapija', 'source_id' => 1047729, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074502', 'part_of_speech' => 'other', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Upotreba lekova u cilju razbijanja ili rastvaranja krvnih ugrušaka, koji su glavni uzrok i srčanog i moždanog udara.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964533276677, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'thrombolytic therapy', 'Definition' => 'Use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke.', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'CCTRADUCTION', 'Creation Date' => '2011/4/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'thrombolytic_therapy', )

(object) array( 'id' => '1460603', 'url' => 'SR/meta-analysis_₁', 'image' => '', 'title' => 'meta-analiza', 'tags' => array ( 0 => 'meta-analiza', 1 => 'Education', 2 => 'Teaching', 3 => 'Teachnology', 4 => '', ), 'term' => 'meta-analiza', 'source_id' => 712334, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Education', ), 'category' => array ( 0 => 'Teaching', ), 'company' => array ( 0 => 'Teachnology', ), 'lastedit' => '20110705082507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Statistička procedura za inegraciju rezultata različitih studija.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964694757377, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'meta-analysis', 'Company' => 'Teachnology', 'Definition' => 'Statistical procedure for integrating the results of different studies.', 'Domain' => 'Documentation', 'Industry' => 'Education', 'Part of Speech' => 'noun', 'Product Category' => 'Teaching', 'Usage Status' => 'New', 'Creation User' => 'katesd', 'Creation Date' => '2011/2/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'meta-analysis_₁', )

(object) array( 'id' => '1461003', 'url' => 'SR/data_safety_and_monitoring_board_(dsmb)', 'image' => '', 'title' => 'Odbor za bezbednost podataka i monitoring', 'tags' => array ( 0 => 'Odbor za bezbednost podataka i monitoring', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Odbor za bezbednost podataka i monitoring', 'source_id' => 30887, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Nezavisni odbor koji se sastoji od predstavnika udruženja i stručnjaka za klinička ispitivanja koji vrše pregled podataka u toku samog kliničkog ispitivanja radi sigurnosti da učestnici nisu izloženi nepotrebnom riziku. ovaj Odbor(DSMB)može predložiti okončanje ispitivanja ukoliko postoji sumnja u bezbedenost iii ukoliko su ciljevi ispitivanja postignuti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907777, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'data safety and monitoring board (dsmb)', 'Definition' => 'An independent committee, composed of community representatives and clinical research experts, that reviews data while a clinical trial is in progress to ensure that participants are not exposed to undue risk. A DSMB may recommend that a trial be stopped if there are safety concerns or if the trial objectives have been achieved.', 'Synonym' => 'DSMB_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'data_safety_and_monitoring_board_(dsmb)', )

(object) array( 'id' => '1461004', 'url' => 'SR/double-blind_study', 'image' => '', 'title' => 'duplo-slepa studija', 'tags' => array ( 0 => 'duplo-slepa studija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'duplo-slepa studija', 'source_id' => 30890, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Klinička studija u kojoj ni pojedinci koji u njoj učestvuju ni stručna lica koja studiju sprovode ne znaju koji ispitanici dobijaju eksperimentalni lek a koji placebo(ili drugu terapiju). Smatra se da duplo-slepa studija daje objektivne rezultate, pošto očekivanja lekara i ispitanika vezana za eksperimentalni lek ne utiču negativno na sam ishod:poznata još pod nazivom duplo-maskirana studija. Vidi slepa-studija,jednostruko-slepa studija i placebo', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907778, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'double-blind study', 'Definition' => 'A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study. See Blinded Study, Single-Blind Study, and Placebo.', 'Synonym' => 'double-masked study_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'double-blind_study', )

(object) array( 'id' => '1461050', 'url' => 'SR/phase_iv_trials', 'image' => '', 'title' => 'Četvrta faza ispitivanja', 'tags' => array ( 0 => 'Četvrta faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Četvrta faza ispitivanja', 'source_id' => 30919, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155512', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Postmarketinške studije za prezentovanje dodatnih informacija uključujući rizike leka, koristi i optimalna upotreba.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966609457152, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iv trials', 'Definition' => 'Post-marketing studies to delineate additional information including the drug\'s risks, benefits, and optimal use.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iv_trials', )

(object) array( 'id' => '1461074', 'url' => 'SR/nightclub_style', 'image' => '', 'title' => 'noćni klub stil', 'tags' => array ( 0 => 'noćni klub stil', 1 => 'Dance', 2 => 'Belly dance', 3 => '', ), 'term' => 'noćni klub stil', 'source_id' => 903174, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Dance', ), 'category' => array ( 0 => 'Belly dance', ), 'lastedit' => '20110705161505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Što se tiče kostima, ovo j že stil koji mnogi ljudi povezuju sa trbušnim plesom - brushalter, kajiš i suknja sa puno perlica i šljokica.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966614700034, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'nightclub style', 'Definition' => 'When applied to costumes, this is the style most people associate with belly dance - a bra, belt, and skirt with lots of beads and sequins.', 'Domain' => 'Documentation; Marketing', 'Industry' => 'Dance', 'Part of Speech' => 'noun', 'Product Category' => 'Belly dance', 'Synonym' => 'cabaret_style', 'Usage Status' => 'New', 'Creation User' => 'cutecee12', 'Creation Date' => '2011/3/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'nightclub_style', )

(object) array( 'id' => '1461311', 'url' => 'SR/Family_and_Medical_Leave_Act', 'image' => '', 'title' => 'Zakon o porodičnom i zdravstvenom odsustvu', 'tags' => array ( 0 => 'Zakon o porodičnom i zdravstvenom odsustvu', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Zakon o porodičnom i zdravstvenom odsustvu', 'source_id' => 40085, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705223510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Ovaj zakon nalaže da poslodavci moraju omogućiti najviše 12 nedelja neplaćenog odsustva kvalifikovanim zaposlenima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813700, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Family and Medical Leave Act', 'Definition' => 'This act stipulates that employers must provide up to 12 weeks of unpaid leave to eligible employees.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Family_and_Medical_Leave_Act', )

(object) array( 'id' => '1461049', 'url' => 'SR/phase_iii_trials', 'image' => '', 'title' => 'Treća faza ispitivanja', 'tags' => array ( 0 => 'Treća faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Treća faza ispitivanja', 'source_id' => 30918, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara opšte prakse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247812, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iii trials', 'Definition' => 'Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iii_trials', )

(object) array( 'id' => '1460602', 'url' => 'SR/modularization', 'image' => '', 'title' => 'modularizacija', 'tags' => array ( 0 => 'modularizacija', 1 => 'Education', 2 => 'Teaching', 3 => 'Teachnology', 4 => '', ), 'term' => 'modularizacija', 'source_id' => 712326, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Education', ), 'category' => array ( 0 => 'Teaching', ), 'company' => array ( 0 => 'Teachnology', ), 'lastedit' => '20110705082506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Obrazovni proces koji razdvaja materijal ili kurseva na module čime se studentima omogućava felksibilnost u izabirz modula priliko kreiranja programa studiranja.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964694757376, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'modularization', 'Company' => 'Teachnology', 'Definition' => 'Teaching process that splits material or courses into modules to allow students flexibility in selecting modules to create a program of study.', 'Domain' => 'Documentation', 'Industry' => 'Education', 'Part of Speech' => 'noun', 'Product Category' => 'Teaching', 'Usage Status' => 'New', 'Creation User' => 'katesd', 'Creation Date' => '2011/2/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'modularization', )

(object) array( 'id' => '1460563', 'url' => 'SR/approved_drugs', 'image' => '', 'title' => 'odobreni lekovi', 'tags' => array ( 0 => 'odobreni lekovi', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'odobreni lekovi', 'source_id' => 30872, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705074505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'U Sjedinjenim Državama, Zavod za zaštitu zdravlja (FDA) mora odobriti supstancu kao lek pre nego bude pušten na tržište. Ovaj proces podrazumeva nekoliko stadijuma uključujući prekliničke laboratorijske studije i studije na životinjama, kliničko testiranje bezbednosti i efikasnosti proizvoda, popunjavanje Prijuave za registraciju novog leka od strane proizvođača samog leka, pregled prijave od strane FDA i odobrenje/odbijanje prijave od strane FDA', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325249, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'approved drugs', 'Definition' => 'In the U.S., the Food and Drug Administration (FDA) must approve a substance as a drug before it can be marketed. The approval process involves several steps including pre-clinical laboratory and animal studies, clinical trials for safety and efficacy, filing of a New Drug Application by the manufacturer of the drug, FDA review of the application, and FDA approval/rejection of application.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'approved_drugs', )